|
Synthesis of new compounds and their nanoparticle formulation for oral and/or topical treatment of leishmaniasis.
|
0011-1307-2015-000022
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2015 GN TECHNOLOGISTS
|
15-06-2015
|
17.000,00€
|
-
|
|
New derivatives for Chagas disease
|
0011-1307-2015-000020
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2015 GN TECHNOLOGISTS
|
11-06-2015
|
17.000,00€
|
-
|
|
Bioinformatics analysis of transcriptomics, epigenomics and metabolomics data
|
0011-1307-2015-000024
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2015 GN TECHNOLOGISTS
|
11-06-2015
|
17.000,00€
|
-
|
|
development of new methods based on comet essay for the assessment genotoxicity of chemical compounds
|
0011-1307-2015-000023
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2015 GN TECHNOLOGISTS
|
11-06-2015
|
17.000,00€
|
-
|
|
CARDIOPATCH: Use of collagen membranes as matrices for the delivery of cellularized grafts in myocardial infarction.
|
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
GN 2015 TECHNOLOGY CENTERS
|
15-05-2015
|
348.250,00€
|
-
|
|
SIMDIACOL: Role of Symbiotics (PROBISAN) in the prevention and development of diabetes and inflammatory bowel diseases in experimental animal models.
|
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
GN 2015 TECHNOLOGY CENTERS
|
15-05-2015
|
233.125,00€
|
-
|
|
OBEKIT: development of a nutrigenetic test for personalized prescription of weight loss diets.
|
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
GN 2015 TECHNOLOGY CENTERS
|
15-05-2015
|
240.000,00€
|
-
|
|
MINECO Stabilization Program I3
|
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
MIG-2014-I3 MINECO
|
10-04-2015
|
130.000,00€
|
-
|
|
Stabilization Program I3 MINECO
|
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
MIG-2014-I3 MINECO
|
10-04-2015
|
130.000,00€
|
-
|
|
In vitro and in vivo cardiac reprogramming by defined factors as a strategy for cardiac regeneration.
|
BES2014-069226
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
2013 - MINECO FPI
|
17-03-2015
|
83.900,00€
|
ERDF funds
|
|
IN VITRO AND IN VIVO CARDIAC REPROGRAMMING BY DEFINED FACTORS AS A CARDIAC REGENERATION STRATEGY
|
BES-2014-069226
|
MINISTRY OF Education, CULTURE AND SPORT
|
Foundation for Applied Medical research
|
MIG-2014-MEC SCHOLARSHIPS (FPI)
|
17-03-2015
|
88.400,00€
|
-
|
|
TARGEPILIVER: Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.
|
657125
|
EUROPEAN COMMISSION
|
Foundation for Applied Medical research
|
H2020-EC-MSCA-GF
|
04-02-2015
|
170.122,00€
|
-
|
|
Integrated next-generation flow cytometry and sequencing to uncover the pathway of curability in multiple myeloma - MYELOMANEXT
|
|
EUROPEAN COMMISSION
|
University of Navarra
|
ERC-2015-STG
|
03-02-2015
|
1.468.606,00€
|
-
|
|
PROCROP: Professional crosspriming for ovarian and prostate cancer
|
635122
|
EUROPEAN COMMISSION
|
Foundation for Applied Medical research
|
H2020-SC
|
13-01-2015
|
1.190.000,00€
|
-
|
|
|
|
|
|
|
|
|
